Spark Therapeutics Aktie
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| United Therapeutics | -1,71 % | 14,44 % | 20,49 % | 81,16 % | 20,15 % | 155,68 % | 261,55 % |
| Ionis Pharmaceuticals Inc. | 2,43 % | 3,81 % | -7,38 % | 119,80 % | -6,89 % | 102,69 % | 66,05 % |
| Novocure Ltd | 0,71 % | -11,37 % | -21,61 % | -47,95 % | -20,12 % | -83,04 % | -91,51 % |
Kommentare
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December



